Skip to content
  • News
  • Compare
  • Capital
variis
  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Events
  • Funds
  • Press
variis

Longevity intelligence for Singapore and Australia. Sourced and evidence-graded.

Directories

  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Funds
  • Events

Read

  • Archive
  • Capital
  • Compare
  • Glossary

Markets

  • Singapore
  • Australia

variis

  • About
  • Editorial standards
  • AI transparency
  • Corrections
  • Press

Legal

  • Medical disclaimer
  • Privacy policy
  • Terms of service

AI-assisted reporting, human-reviewed. Every claim sourced and graded. Not medical advice.

© 2026 variis · Singapore · Australia

Compare

Longevity protocols, side by side.

Pick the protocols you want, then compare them on one table: evidence level, categories, and sources, all graded and dated.

ClinicsCompaniesProtocols

Pick two or more to compare them side by side.

Market

49 to choose from

Protocol

Protocol

Advanced lipid panel (ApoB and Lp(a))

Clinical evidence

Protocol

Protocol

Autologous stem cell therapy

Commercial evidence

Protocol

Protocol

Bioidentical hormone therapy

Commercial evidence

Protocol

Protocol

BPC-157

Commercial evidence

Protocol

Protocol

Collagen supplementation

Commercial evidence

Protocol

Protocol

Continuous glucose monitoring (CGM) in non-diabetics

Commercial evidence

Protocol

Protocol

Contrast therapy

Commercial evidence

Protocol

Protocol

Coronary artery calcium (CAC) scoring

Clinical evidence

Protocol

Protocol

Creatine monohydrate supplementation

Clinical evidence

Protocol

Protocol

DEXA body composition and bone density scanning

Clinical evidence

Protocol

Protocol

Dry flotation therapy

Commercial evidence

Protocol

Protocol

Epigenetic / DNA-methylation biological age clock

Commercial evidence

Protocol

Protocol

Epithalon

Commercial evidence

Protocol

Protocol

Exosome therapy

Commercial evidence

Protocol

Protocol

Fasting-mimicking diet (ProLon-style 5-day cycles)

Clinical evidence

Protocol

Protocol

Full-body MRI screening

Commercial evidence

Protocol

Protocol

GHK-Cu (copper peptide)

Commercial evidence

Protocol

Protocol

GLP-1 receptor agonists (semaglutide, tirzepatide)

Clinical evidence

Protocol

Protocol

Growth hormone (recombinant somatropin) therapy

Clinical evidence

Protocol

Protocol

Growth hormone secretagogues: CJC-1295 and ipamorelin

Mechanism evidence

Protocol

Protocol

Hyperbaric oxygen therapy (HBOT)

Commercial evidence

Protocol

Protocol

Infrared sauna

Commercial evidence

Protocol

Protocol

Intermittent hypoxic-hyperoxic training (IHHT)

Commercial evidence

Protocol

Protocol

Low-dose naltrexone (LDN)

Preclinical evidence

Protocol

Protocol

Menopausal hormone therapy (MHT)

Clinical evidence

Protocol

Protocol

Metformin (off-label for healthspan / metabolic optimisation)

Preclinical evidence

Protocol

Protocol

Multi-cancer early detection liquid biopsy (ctDNA)

Commercial evidence

Protocol

Protocol

NAD+ IV infusion

Commercial evidence

Protocol

Protocol

Nicotinamide riboside (NR) supplementation

Mechanism evidence

Protocol

Protocol

NMN supplementation

Mechanism evidence

Protocol

Protocol

Omega-3 fatty acid supplementation

Clinical evidence

Protocol

Protocol

Personalised supplement protocol (biomarker-guided stack)

Commercial evidence

Protocol

Protocol

Platelet-rich plasma (PRP)

Commercial evidence

Protocol

Protocol

Pulsed electromagnetic field therapy (PEMF)

Commercial evidence

Protocol

Protocol

Rapamycin / sirolimus (off-label, low-dose intermittent)

Preclinical evidence

Protocol

Protocol

Red light therapy / photobiomodulation

Commercial evidence

Protocol

Protocol

Sleep optimisation protocol (circadian timing, sleep tracking, home sleep studies)

Commercial evidence

Protocol

Protocol

Spermidine supplementation

Preclinical evidence

Protocol

Protocol

Structured resistance training and strength/functional prescription

Clinical evidence

Protocol

Protocol

Taurine supplementation

Preclinical evidence

Protocol

Protocol

Testosterone replacement therapy (TRT)

Clinical evidence

Protocol

Protocol

Therapeutic plasma exchange (TPE)

Commercial evidence

Protocol

Protocol

Thymosin alpha-1 and thymosin beta-4 (TB-500)

Preclinical evidence

Protocol

Protocol

Thyroid assessment and optimisation

Clinical evidence

Protocol

Protocol

Time-restricted eating / intermittent fasting prescription

Clinical evidence

Protocol

Protocol

Vitamin D supplementation

Clinical evidence

Protocol

Protocol

VO2max / cardiopulmonary exercise testing

Clinical evidence

Protocol

Protocol

Whole-body cryotherapy

Commercial evidence

Protocol

Protocol

Zone 2 aerobic training prescription

Clinical evidence

Capital · AustraliaEverlab closes an AU$65M Series A16 JunCorporate · GlobalResMed acquires Noctrix Health1 JunClinic · SingaporeNOVI partners with Novo Nordisk1 JunTrial milestone · SingaporePROMETHEUS advances to the XPRIZE Healthspan finals15 AprClinic · SingaporeSPARKD relocates to Four Seasons1 AprRegulatory · GlobalFDA approves oral orforglipron (Foundayo)1 AprClinic · SingaporeRaffles launches R17 longevity clinic1 FebClinic · SingaporeThe Longevity GP launches1 FebCapital · AustraliaEverlab closes an AU$65M Series A16 JunCorporate · GlobalResMed acquires Noctrix Health1 JunClinic · SingaporeNOVI partners with Novo Nordisk1 JunTrial milestone · SingaporePROMETHEUS advances to the XPRIZE Healthspan finals15 AprClinic · SingaporeSPARKD relocates to Four Seasons1 AprRegulatory · GlobalFDA approves oral orforglipron (Foundayo)1 AprClinic · SingaporeRaffles launches R17 longevity clinic1 FebClinic · SingaporeThe Longevity GP launches1 Feb

News

  • Singapore launches SPICE program to screen and prevent decline in older adults
  • GLP-1s and healthspan: a 2026 reader’s primer
  • New trial to test precision geromedicine for healthy ageing
Read all news →

Markets

22

dated moves tracked

Latest: Everlab closes an AU$65M Series ASee the capital desk →